Adaptive Biotechnologies Corporation has grown revenue 18% a year over three years and 18% a year over five. Revenue growth, 3-year annual rate: +18% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +18%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

ADPTAdaptive Biotechnologies Corporation

Healthcare

$26.49+98% 1Y

$26.49

$12.4152 weeks$29.86

Is it growing?

Good

Growing: revenue growing +50% year on year and operating margin widening (+46.1 points).

2 good, 1 without data

Revenue trend+50% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +18% a year.

Margin direction+46.1 points operating

Trailing-twelve-month operating margin, -14.0% now against -60.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ADPT growing?

Adaptive Biotechnologies Corporation has grown revenue 18% a year over three years and 18% a year over five.

+18%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›